NCT03778814View on ClinicalTrials.gov

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 30, 2029

Study Completion Date

December 30, 2036

Conditions
Nonsmall Cell Lung CancerSolid Tumor, Adult
Interventions
BIOLOGICAL

TCR-T cells

Engineering TCR-T cells targeting lung tumor and other solid tumor will be transfused back the patients.

Trial Locations (1)

51260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guanzhou

All Listed Sponsors
collaborator

Tcell Immune (Guangzhou) Science and Technology Ltd.

UNKNOWN

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER